News and Analysis
Innovation, Technology, and IP News
If a Case Was Baseless, It Would Have Ended Sooner
Written by: Matthew Pham & Daniel P. Hughes OneSubsea IP UK Limited v. FMC Technologies, Inc. Before Clevenger, Moore, and Dyk. Appeal from the United States District...
Low-Bar for Corroboration
Written by: Matthew Friedrichs & Daniel P. Hughes MEDTRONIC, INC. v. TELEFLEX INNOVATIONS S.A.R.L. Before Moore, Lourie, and Dyk. Appeal from the Patent Trial and Appeal...
Trademark Monitoring and Enforcement in the Digital Era: Tools and Techniques
In today's digital landscape, protecting your trademarks has become more challenging than ever before. With the rise of e-commerce platforms, social media, and online marketplaces, ...
Exploring the Use of Machine Learning in Prior Art Search: Advancing Patent Examination Efficiency
In the realm of patent examination, the search for prior art plays a critical role in determining the novelty and inventiveness of an invention. Traditionally, patent examiners...
Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy
Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has started with extensive layoffs throughout the...
Feed tagged as "Patentability":
IN RE KILLIAN
Before Taranto, Clevenger, and Chen. Appeal from the Patent Trial and Appeal Board.
Summary: Section 101... Read More »
INTEL CORPORATION v. QUALCOMM INCORPORATED
Before Prost, Taranto, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: Indefinite claims do not ... Read More »
No, my site did not get overrun by the pharmaceutical pushers that like to submit "advice" in the comments section. The title is referring to entity size... Read More »
Below is an animated visualization of the subject matter eligibility 101 roller coaster that patent prosecutors and examiners have been on over the past 5 years. The... Read More »
Sitting en banc, a fractured Federal Circuit (Appeal no. 2015-1177 (Fed. Cir., Oct. 4, 2017)) released 140+ pages comprising five separate opinions (7 Judges... Read More »
Written by Peter E. Heuser, Schwabe, Williamson & Wyatt, P.C.
In almost 150 pages and five separate opinions, a majority of an en banc Circuit remands to the... Read More »
Written by Peter E. Heuser, Schwabe, Williamson & Wyatt
In Nidec v. Zhongshan, the entire panel affirms a determination of obviousness but two judges question ... Read More »
In Regeneron Pharmaceuticals v. Merus N.V., Appeal No. 2016-1346 (Fed. Cir., July 27, 2017), a split three-judge panel of Prost, Wallach and Newman (Newman... Read More »
In the fourth of a recent series of appellate decisions establishing patent-eligibility of patent claims post-Alice, in McRO, Inc. v. Bandai Namco Games... Read More »
Each country has its own patent system, and no authority can issue a patent enforceable in any other country. Because today’s increasingly global economy... Read More »
Last week’s article detailed prior art and patentability, and defined prior art as all information pertinent to a patent that was publicly available before that ... Read More »
Patents exist to promote innovation. By granting a federally recognized documents to inventors with a new idea, the government is able to make these ideas public... Read More »
I have a confession to make -- I never learned to sew. Perhaps I can blame this on growing up during the 50s and 60s before gender-based roles loosened... Read More »
It is said that a living organism is as old as its stem cells. And a research group led by the Buck Institute for Research on Aging and the Georgia Institute of... Read More »
The US Court of Appeals has ruled that isolated genes from human DNA structures are patentable in the case of The Association for Molecular Pathology... Read More »
Comments
Gena PatentAlthough a bit of trepidation is likely in order (no matter on what end of the spectrum you tend to fall), I look forward to reading what the SCOTUS has to say when the esteemed Justices opine on gene patents. Particularly since Myriad presents a bit of a chicken-and-egg question -- that is thus perhaps not scientifically, definitively solvable -- policy considerations will probably weigh heavily in their ultimate determination. Which also makes one wonder to what extent the Court's new political makeup will affect the case's outcome.http://www.GeneralPatent.com/blog/
Aug 9, 2011
On June 28 2010, the US Supreme Court issued its opinion in Bilski v. Kappos, which is an important opinion on the issue of the patentability of business methods. In the ... Read More »
